Dan Brennan
Stock Analyst at TD Cowen
(4.32)
# 442
Out of 5,044 analysts
114
Total ratings
58.06%
Success rate
15.14%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Maintains: Buy | $612 → $654 | $558.31 | +17.14% | 13 | Oct 23, 2025 | |
| DHR Danaher | Maintains: Buy | $250 → $260 | $214.01 | +21.49% | 6 | Oct 22, 2025 | |
| A Agilent Technologies | Maintains: Buy | $150 → $162 | $143.20 | +13.13% | 13 | Oct 14, 2025 | |
| GH Guardant Health | Maintains: Buy | $63 → $72 | $72.27 | -0.37% | 3 | Sep 25, 2025 | |
| NEO NeoGenomics | Maintains: Buy | $10 → $12 | $10.28 | +16.73% | 7 | Sep 12, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $13 → $15 | $16.80 | -10.71% | 1 | Aug 6, 2025 | |
| CAI Caris Life Sciences | Initiates: Buy | $32 | $29.43 | +8.73% | 1 | Jul 14, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $135 → $110 | $131.76 | -16.51% | 4 | May 1, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $8 → $2.5 | $3.07 | -18.57% | 4 | Mar 21, 2025 | |
| TEM Tempus AI | Reinstates: Buy | $74 | $88.84 | -16.70% | 2 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $86 | $62.74 | +37.07% | 6 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $155 → $175 | $192.81 | -9.24% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $250 | $180.15 | +38.77% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $72 → $70 | $37.74 | +85.48% | 1 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $166 → $177 | $95.03 | +86.26% | 12 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $141 → $144 | $95.30 | +51.10% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $363 → $410 | $343.47 | +19.37% | 3 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $7.91 | +279.27% | 1 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $11.58 | +167.70% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $40.21 | +26.83% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $6.54 | +756.27% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $12.90 | +148.06% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $170.30 | +220.61% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $4.81 | +45.53% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $2.01 | +646.27% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $165.95 | +39.80% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,394.17 | -36.88% | 3 | Oct 7, 2020 |
Thermo Fisher Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $612 → $654
Current: $558.31
Upside: +17.14%
Danaher
Oct 22, 2025
Maintains: Buy
Price Target: $250 → $260
Current: $214.01
Upside: +21.49%
Agilent Technologies
Oct 14, 2025
Maintains: Buy
Price Target: $150 → $162
Current: $143.20
Upside: +13.13%
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $63 → $72
Current: $72.27
Upside: -0.37%
NeoGenomics
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $10.28
Upside: +16.73%
Adaptive Biotechnologies
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $16.80
Upside: -10.71%
Caris Life Sciences
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $29.43
Upside: +8.73%
GeneDx Holdings
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $131.76
Upside: -16.51%
Maravai LifeSciences Holdings
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $3.07
Upside: -18.57%
Tempus AI
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $88.84
Upside: -16.70%
Nov 26, 2024
Maintains: Buy
Price Target: $82 → $86
Current: $62.74
Upside: +37.07%
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $192.81
Upside: -9.24%
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $180.15
Upside: +38.77%
Nov 6, 2024
Maintains: Hold
Price Target: $72 → $70
Current: $37.74
Upside: +85.48%
Nov 5, 2024
Maintains: Buy
Price Target: $166 → $177
Current: $95.03
Upside: +86.26%
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $95.30
Upside: +51.10%
Nov 4, 2024
Maintains: Hold
Price Target: $363 → $410
Current: $343.47
Upside: +19.37%
Aug 7, 2024
Maintains: Hold
Price Target: $28 → $30
Current: $7.91
Upside: +279.27%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $11.58
Upside: +167.70%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $40.21
Upside: +26.83%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $6.54
Upside: +756.27%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $12.90
Upside: +148.06%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $170.30
Upside: +220.61%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $4.81
Upside: +45.53%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $2.01
Upside: +646.27%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $165.95
Upside: +39.80%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,394.17
Upside: -36.88%